357 related articles for article (PubMed ID: 21864935)
1. Melanocyte-keratinocyte transplantation procedure in the treatment of vitiligo: the experience of an academic medical center in the United States.
Huggins RH; Henderson MD; Mulekar SV; Ozog DM; Kerr HA; Jabobsen G; Lim HW; Hamzavi IH
J Am Acad Dermatol; 2012 May; 66(5):785-93. PubMed ID: 21864935
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of patients undergoing autologous noncultured melanocyte-keratinocyte transplantation for vitiligo and other leukodermas.
Silpa-Archa N; Griffith JL; Huggins RH; Henderson MD; Kerr HA; Jacobsen G; Mulekar SV; Lim HW; Hamzavi IH
J Am Acad Dermatol; 2017 Aug; 77(2):318-327. PubMed ID: 28502377
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation.
Mulekar SV
Arch Dermatol; 2004 Oct; 140(10):1211-5. PubMed ID: 15492183
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up study of 142 patients with vitiligo vulgaris treated by autologous, non-cultured melanocyte-keratinocyte cell transplantation.
Mulekar SV
Int J Dermatol; 2005 Oct; 44(10):841-5. PubMed ID: 16207186
[TBL] [Abstract][Full Text] [Related]
5. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
[TBL] [Abstract][Full Text] [Related]
6. Uncommon responses of segmental vitiligo to melanocyte-keratinocyte transplantation procedure.
Isedeh P; Al Issa A; Lim HW; Mulekar SS; Mulekar SV
J Cutan Med Surg; 2015; 19(2):177-81. PubMed ID: 25775633
[TBL] [Abstract][Full Text] [Related]
7. Autologous melanocyte-keratinocyte suspension in the treatment of vitiligo.
El-Zawahry BM; Zaki NS; Bassiouny DA; Sobhi RM; Zaghloul A; Khorshied MM; Gouda HM
J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):215-20. PubMed ID: 20569286
[TBL] [Abstract][Full Text] [Related]
8. Non-cultured melanocyte-keratinocyte transplantation for the treatment of vitiligo: a clinical trial in an Iranian population.
Toossi P; Shahidi-Dadras M; Mahmoudi Rad M; Fesharaki RJ
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1182-6. PubMed ID: 21214632
[TBL] [Abstract][Full Text] [Related]
9. A retrospective study of long term follow-up of 2283 vitiligo patients treated by autologous, non-cultured melanocyte-keratinocyte transplantation.
Zhang D; Wei X; Hong W; Fu L; Qian G; Xu AE
Aging (Albany NY); 2021 Feb; 13(4):5415-5425. PubMed ID: 33582653
[TBL] [Abstract][Full Text] [Related]
10. Stable vitiligo treated by a combination of low-dose oral pulse betamethasone and autologous, noncultured melanocyte-keratinocyte cell transplantation.
Mulekar SV
Dermatol Surg; 2006 Apr; 32(4):536-41. PubMed ID: 16681662
[TBL] [Abstract][Full Text] [Related]
11. Treatment of vitiligo on difficult-to-treat sites using autologous noncultured cellular grafting.
Mulekar SV; Al Issa A; Al Eisa A
Dermatol Surg; 2009 Jan; 35(1):66-71. PubMed ID: 19076191
[TBL] [Abstract][Full Text] [Related]
12. Treatment of vitiligo with a melanocyte-keratinocyte cell suspension versus dermabrasion only: a pilot study with a 12-month follow up.
Vázquez-Martínez OT; Martínez-Rodríguez HG; Velásquez-Arenas L; Baños-González D; Ortíz-López R; Padilla-Rivas G; Welsh O; Ocampo-Candiani J
J Drugs Dermatol; 2011 Sep; 10(9):1032-6. PubMed ID: 22052273
[TBL] [Abstract][Full Text] [Related]
13. Noncultured epidermal suspension transplantation for the treatment of stable vitiligo in children and adolescents.
Sahni K; Parsad D; Kanwar AJ
Clin Exp Dermatol; 2011 Aug; 36(6):607-12. PubMed ID: 21507039
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of noncultured melanocyte-keratinocyte transplant procedure for vitiligo and other leukodermas: a critical analysis of the evidence.
Vakharia PP; Lee DE; Khachemoune A
Int J Dermatol; 2018 Jul; 57(7):770-775. PubMed ID: 29318598
[TBL] [Abstract][Full Text] [Related]
15. Recipient-to-Donor Ratios in the Surgical Treatment of Vitiligo, Leukoderma, and Piebaldism: A Retrospective Review.
Maghfour J; Bardhi R; Huggins R; Hamzavi IH; Mohammad TF
Dermatology; 2023; 239(5):828-831. PubMed ID: 37231873
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of 2-mm punch grafting in patients with vitiligo vulgaris and segmental vitiligo: effect of disease activity.
Fongers A; Wolkerstorfer A; Nieuweboer-Krobotova L; Krawczyk P; Tóth GG; van der Veen JP
Br J Dermatol; 2009 Nov; 161(5):1105-11. PubMed ID: 19673878
[TBL] [Abstract][Full Text] [Related]
17. Autologous noncultured melanocyte transplantation for stable vitiligo: can suspending autologous melanocytes in the patients' own serum improve repigmentation and patient satisfaction?
Sahni K; Parsad D; Kanwar AJ; Mehta SD
Dermatol Surg; 2011 Feb; 37(2):176-82. PubMed ID: 21269348
[TBL] [Abstract][Full Text] [Related]
18. Ratio of size of recipient and donor areas in treatment of vitiligo by autologous cultured melanocyte transplantation.
Hong WS; Hu DN; Qian GP; McCormick SA; Xu AE
Br J Dermatol; 2011 Sep; 165(3):520-5. PubMed ID: 21564070
[TBL] [Abstract][Full Text] [Related]
19. Punch grafting for lip leucoderma.
Malakar S; Lahiri K
Dermatology; 2004; 208(2):125-8. PubMed ID: 15057001
[TBL] [Abstract][Full Text] [Related]
20. Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases.
Chen YF; Yang PY; Hu DN; Kuo FS; Hung CS; Hung CM
J Am Acad Dermatol; 2004 Jul; 51(1):68-74. PubMed ID: 15243526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
